Navigation Links
Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share
Date:1/26/2011

for the rest of the year."

First quarter revenue highlights include:

-- North America Acute Care.  North America Acute Care revenue grew 6 percent to $218 million.  Capital sales increased 12 percent due primarily to higher sales of patient support systems, which grew 22 percent. Rental revenue declined 7 percent.

-- International.  International revenue increased 7 percent to $104 million. On a constant currency basis, revenue increased 11 percent, due to strong performance in the Middle East, Latin America and Asia.

-- North America Post-Acute Care.  North America Post-Acute Care revenue declined 1 percent to $52 million. Capital sales declined 3 percent while rental revenue was the same as the prior year.  Respiratory and Home Care gains were more than offset by declines in the Extended Care business.

First Quarter Financial and Operational Highlights-- Operating margin increased 360 basis points to 13.3 percent, compared to 9.7 percent in the first quarter of last year.

-- Operating cash flow was $24 million, compared to $22 million in the first quarter of the prior year, as the impact of stronger earnings was partially offset by increases in working capital.

-- During the quarter the Company completed the acquisition of the minority interest in the previously established Encompass joint venture, enhancing our position in the surface replacement segment.  

-- Diluted earnings per share reflect the favorable impact of a lower tax rate, due in part to the reinstatement of the R&D tax credit retroactively to January 1, 2010 and increased earnings in lower tax rate jurisdictions.Please see the attached schedules for additional information, including condensed financial information, summary balance sheet, cash flow statement and segment sales summaries.  

For a more complete review of Hill-Rom's results, please refer to our Quarterly Report
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
2. Hill-Rom Announces Corporate Governance Enhancements
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
4. Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter
5. Hill-Rom and Encompass Group Form Joint Venture
6. Hill-Rom to Host Investors Conference in New York City
7. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
8. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
9. Hill-Rom Introduces Smart Bed Technology into CareAssist(R) ES Bed
10. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
11. Hill-Rom Extends Smart Bed Features for High-Tech Hospital Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... 16, 2013  Today, the National Patient Advocate Foundation ... House of Representatives recently approved a bill that would ... patients higher out-of-pocket fees for newer, more expensive oral ... have more severe side-effects. However, the bill was amended ... will continue to be a barrier to patients with ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... STAA ) today announced that it will release financial results for ... 2, 2009 after the market close. ... Tuesday, November 3, 2009 at 10:00 a.m. Eastern / 7:00 a.m. ... quarter results and current corporate developments. The timing of the release ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion ... the treatment of obesity. These data expand on top-line ... discussion on Saturday where the Company presented data on Contrave ...
Cached Medicine Technology:STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call 2Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 2Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 3Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 4Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 5Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 6
(Date:5/19/2013)... 2013 People in Minnesota have a great ... is offering its 28 Day Fat Loss Formula. The ... comfort of their own home. The product sells for $135 ... can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season ... houses now, but after using the 28 Day Fat Loss ...
(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...
(Date:5/19/2013)... According to a new market research report ... 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, ... IS, Infrared, X-Ray) And Geography" published by MarketsandMarkets, ... billion in 2012 and is expected to reach ... of 3.84% from 2013 to 2018. In terms ...
(Date:5/19/2013)... May 19, 2013 The report “Feed ... Trends & Forecasts up to 2017” published by MarketsandMarkets, ... with analysis and forecasting of the global volume and ... the driving and restraining factors for the global market ... and challenges. The market is segmented and revenue is ...
(Date:5/19/2013)... Americans live closer to their dogs than ever ... Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, more ... a member of the family, up from the 53.5% ... earlier. , According to the American Pet Products Association, ... to pets has increased every year without interruption, including ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... A consortium of federal agencies and nongovernmental organizations has ... and data-collection methods for use in asthma clinical research. ... Outcomes Workshop, which appears as a supplement to the ... and Clinical Immunology , resulted from a meeting organized ...
... FRIDAY, March 2 (HealthDay News) -- Women become less likely ... first year of college, new research finds. Declining condom ... had worse grades and who came from poorer backgrounds. ... unplanned pregnancies and sexually transmitted diseases, yet there has been ...
... people who consume drugs containing cannabinoid compounds found in ... Marsicano (Inserm Research Unit 862) in collaboration with a ... mechanism by which these substances affect working memory. These ... adverse effect of cannabinoids on working memory is exerted ...
... in childhood have a higher risk of infertility in ... Balcerek and her co-authors in a study published in ... 109[7] 126-31). , In a nationwide German survey on ... the authors collected data from former pediatric oncology patients. ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, March ... to screen for cervical cancer are more likely to survive ... Swedish study suggests. Compared to women whose cervical cancer ... Pap smear increased their cure rate from 66 percent to ...
... news for the 27,000 plus people around the world who ... living kidney donors for 10 years found that they were ... general population. Led by Dr. Amit Garg, ... London Health Sciences Centre, the results provide important safety reassurances ...
Cached Medicine News:Health News:Standardized outcome measures proposed for asthma clinical research 2Health News:College Women's Condom Use Falls During Freshman Year 2Health News:How does cannabis affect working memory? 2Health News:How does cannabis affect working memory? 3Health News:Regular Pap Smear Boosts Cervical Cancer Survival: Study 2Health News:Regular Pap Smear Boosts Cervical Cancer Survival: Study 3Health News:First study of its kind finds no increased risk of heart disease for kidney donors 2
Irrigating Cystotome, Straight, 25 g. Overall length 15 mm. 5/box....
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 23 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Lamellar Blade tip 6600 style, angled bevel up. Dimensions: 11.0 mm (L) x 2.4 mm (W). Cut: 3.7 mm....
Medicine Products: